Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 179.50
Bid: 175.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.714%)
Open: 179.50
High: 0.00
Low: 0.00
Prev. Close: 179.50
CPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Globiva Divestment

27 Nov 2023 07:00

RNS Number : 6728U
CPPGroup Plc
27 November 2023
 

27 November 2023

CPPGroup Plc

("the Group"; or "the Company")

 

Globiva Divestment

 

CPP Group (AIM: CPP), a provider of real-time assistance products and resolution services which reduce disruptions to everyday life for millions of customers across the world, has entered into an agreement (the "Agreement") with the founders of Globiva Services Private Ltd ("Globiva") for the disposal of the Group's majority interest in Globiva for an aggregate consideration of approximately £5.1 million1 (the "Transaction"). Globiva is non-core to the Group following the announcement of its revised strategy and Change Management Programme ("CMP") in October 2022 to transform the Group to an InsurTech business, led by Blink Parametric ("Blink").

 

Background

The Group holds a 51% majority interest in Globiva, a Business Processes Management company incorporated in India, with the other 49% of the shares beneficially owned by the three founders of Globiva, Navneet Gupta, Vikram Singh Nathawat, and Ashish Goyal, who continue to manage the business (the "Globiva Founders").

 

Under amended arrangements entered into on 20 July 2022, the Globiva Founders had the option to buy back 10% of the ordinary shares in Globiva, from the Group, for a pre-agreed price of approximately £0.9 million. This was subject to Globiva meeting certain performance targets, which it is on track to achieve. However, in the normal course of business, it was further agreed that this could not be triggered until 1 January 2026 at the earliest. This Agreement supersedes the previous arrangements.

 

Transaction Rationale

· The Transaction is consistent with the Group's stated strategy to transform the Group to an InsurTech business led by Blink and supported by India and Turkey.

· The Group is currently a "trapped" investor in Globiva with limited options to realise value. In addition, the Group was likely to become a minority shareholder (January 2026) and consequently would have lost majority voting rights on key strategic decisions. The Transaction provides an exit path for the Group at an acceptable return.

· The Transaction provides cash flow, not previously forecast, over a three-year period to support the Group's CMP.

 

Transaction Structure

· The sale and transfer of ownership will be conducted over a three-year period concluding in Q1 2027.

· The total aggregate consideration of approximately £5.1 million1 (515 million Indian rupees) represents a blended 7.1x multiple on forecast EBITDA for the 2023, 2024 and 2025 calendar years. Final consideration will be based on audited EBITDA and subject to a maximum adjustment of plus or minus ten percent.

· The Group's shareholding in Globiva, currently 51%, will reduce to approximately 35% in Q1 2025; 13% in Q1 2026; and zero percent in Q1 2027.

· Cash, subject to any EBITDA performance adjustment (noted above) will be received by the Group as follows: approximately £1.2 million in 2024; £1.3 million in 2025; £1.2 million in 2026; and £1.4 million in 2027.

 

For the 2022 financial year, Globiva contributed EBITDA of £2.4 million to the Group's overall EBITDA from continuing operations of £6.9 million, albeit the Group's shareholders only ultimately benefit from 51% of Globiva's results. As at 30 June 2023, Globiva had net assets of £3.6 million.

The Transaction constitutes a related party transaction, pursuant to Rule 13 of the AIM Rules for Companies, as the Globiva Founders are Directors of Globiva. The Group's Directors consider, having consulted with the Company's nominated adviser, Liberum Capital Limited, that the terms of the Transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

Simon Pyper, Group CEO, commented:

"The agreement we have reached with Globiva is consistent with our stated strategy and provides a positive outcome for both parties. This is another forward step as we simplify the Group and transform to an InsurTech business."

 

1 Approximate, as subject to currency exchange movements.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Enquiries:

 

CPP Group plc

Simon Pyper, Chief Executive Officer Tel: +44 (0)7917 795601

David Bowling, Chief Financial Officer

 

 

Liberum Capital Limited

(Nominated Adviser and Sole Broker) Tel: +44 (0)20 3100 2000

Richard Lindley

Lauren Kettle

 

About CPP Group:

CPP Group is a technology-driven assistance company that creates embedded and ancillary real-time assistance products and resolution services that reduce disruption to everyday life for millions of people across the world, at the time and place they are needed, CPP Group is listed on AIM, operated by the London Stock Exchange.

 

For more information on CPP visit https://corporate.cppgroup.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBFBLTMTTTBLJ
Date   Source Headline
23rd Dec 20146:33 pmRNSStatement re Close of Formal Sale Process
5th Dec 20149:18 amRNSStatement re Customer Redress and Associated Costs
1st Dec 20149:18 amRNSForm 8.5 (EPT/RI)
28th Nov 20145:03 pmRNSForm 8 (OPD) CPPGroup PLC - Replacement
27th Nov 20144:51 pmRNSForm 8 (OPD) - CPPGroup Plc
26th Nov 20141:26 pmRNSForm 8.3 - CPP Group plc
17th Nov 20143:06 pmRNSForm 8.3 - [CPP Group plc]
17th Nov 20142:31 pmBUSForm 8.3 - CPP Group Plc
14th Nov 20147:00 amRNSTrading Statement
2nd Oct 201410:45 amRNSTotal Voting Rights
23rd Sep 20149:00 amRNSBlocklisting Interim Review
8th Sep 20142:50 pmRNSStatement re Scheme of Arrangement
2nd Sep 20141:33 pmRNSAdditional Listing
29th Aug 20147:00 amRNSHalf Yearly Report
8th Aug 201411:48 amRNSAdditional Listing
31st Jul 20143:31 pmRNSBlocklisting Interim Review
2nd Jul 20147:00 amRNSStatement re Pre-close Announcement
30th Jun 20144:22 pmRNSHolding(s) in Company
17th Jun 201411:42 amRNSResult of AGM
10th Jun 20144:35 pmRNSPrice Monitoring Extension
6th Jun 20142:46 pmRNSScheme of arrangement
6th Jun 201412:41 pmRNSStatement re CPP
2nd Jun 201410:43 amRNSTotal Voting Rights
15th May 20147:00 amRNSInterim Management Statement
14th May 20142:12 pmRNSNotice of AGM
1st May 20144:11 pmRNSTotal Voting Rights
28th Apr 20143:06 pmRNSAnnual Financial Report
24th Apr 20147:00 amRNSAnnual Financial Report
9th Apr 20144:07 pmRNSReplacement Holding(s) in Company
8th Apr 20148:48 amRNSHolding(s) in Company
3rd Apr 20149:33 amRNSTotal Voting Rights
24th Mar 20141:38 pmRNSDisposal
19th Mar 201410:00 amRNSDirector Declaration
27th Feb 201410:03 amRNSChange of Adviser
29th Jan 20147:00 amRNSDirectorate Change
14th Jan 201412:13 pmRNSStatement re Scheme of Arrangement
9th Jan 201411:46 amRNSStatement re Proposed Scheme of Arrangement
2nd Jan 20147:00 amRNSDirector/PDMR Shareholding
20th Dec 20137:00 amRNSPre Close Announcement & Board Changes
1st Nov 20133:49 pmRNSTotal Voting Rights
30th Oct 201312:26 pmRNSCompany Secretary Change
30th Oct 20137:00 amRNSInterim Management Statement
7th Oct 20132:32 pmRNSDirectorate Change
18th Sep 201312:01 pmRNSDirector Declaration
3rd Sep 201310:30 amRNSDirectorate Change
30th Aug 201310:50 amRNSDirectorate Change
22nd Aug 20137:00 amRNSHalf Yearly Report
16th Aug 201310:13 amRNSNotice of Results
6th Aug 20134:40 pmRNSSecond Price Monitoring Extn
6th Aug 20134:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.